Invention Grant
US09206421B2 Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
有权
脂质配制组合物和抑制血清淀粉样蛋白A基因表达的方法
- Patent Title: Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
- Patent Title (中): 脂质配制组合物和抑制血清淀粉样蛋白A基因表达的方法
-
Application No.: US14012909Application Date: 2013-08-28
-
Publication No.: US09206421B2Publication Date: 2015-12-08
- Inventor: Antonin de Fougerolles , Tatiana Novobrantseva , Gregory Hinkle
- Applicant: Alnylam Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Fenwick & West LLP
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; A61K48/00 ; C12N15/63 ; C12N15/85 ; C12N15/113
Abstract:
The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a Serum Amyloid A (SAA) gene, and methods of using the dsRNA to inhibit expression of SAA.
Public/Granted literature
- US20140179759A1 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene Public/Granted day:2014-06-26
Information query
